Quantbot Technologies’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Buy
6,102
+3,845
+170% +$308K 0.02% 921
2026
Q1
$174K Sell
2,257
-20,965
-90% -$1.64M 0.01% 1212
2025
Q4
$1.83M Sell
23,222
-22,632
-49% -$1.96M 0.06% 474
2025
Q3
$4.2M Buy
45,854
+37,809
+470% +$3.08M 0.11% 260
2025
Q2
$525K Sell
8,045
-11,540
-59% -$751K 0.01% 996
2025
Q1
$1.31M Buy
+19,585
New +$1.17M 0.04% 591
2024
Q2
Sell
-719
Closed -$49.7K 1409
2024
Q1
$49.7K Buy
+719
New +$43.4K ﹤0.01% 1331
2023
Q4
Sell
-1,287
Closed -$74.7K 1548
2023
Q3
$74.7K Sell
1,287
-3,730
-74% -$215K 0.01% 1160
2023
Q2
$270K Buy
5,017
+3,869
+337% +$171K 0.02% 863
2023
Q1
$45.6K Buy
+1,148
New +$48.4K ﹤0.01% 1265
2022
Q3
Sell
-1,400
Closed -$41K 1563
2022
Q2
$41K Sell
1,400
-900
-39% -$26K ﹤0.01% 1336
2022
Q1
$64K Buy
+2,300
New +$85.8K 0.01% 1141
2019
Q4
Sell
-395
Closed -$28K 1199
2019
Q3
$28K Buy
395
+295
+295% +$22.1K ﹤0.01% 1069
2019
Q2
$8K Buy
+100
New +$7.11K ﹤0.01% 1102
2017
Q3
Sell
-142
Closed -$6K 1162
2017
Q2
$6K Buy
+142
New +$6.85K ﹤0.01% 1051

Other funds holding ANIP

Quantbot Technologies's ANIP Position: Q2 2026 in Review

Quantbot Technologies increased its ANI Pharmaceuticals (ANIP) stake by 170% in Q2 2026, buying an estimated $308K and bringing the position to 6,102 shares worth $505K. The position accounts for 0.02% of the portfolio, ranked #921.

Quantbot Technologies first reported a position in ANIP in Q2 2017 and has held it in 15 quarters since. The position peaked at $4.2M in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Quantbot Technologies held 6,102 shares of ANI Pharmaceuticals worth $505K as of Q2 2026.
  • Quantbot Technologies bought 3,845 ANI Pharmaceuticals shares in Q2 2026, an estimated $308K.
  • ANI Pharmaceuticals made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #921 holding.
  • Quantbot Technologies first reported a position in ANI Pharmaceuticals in Q2 2017 and has held it in 15 quarters since.
  • Quantbot Technologies's ANI Pharmaceuticals position peaked at $4.2M in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.